Not just the approved indications: FDA to study DTC drug ads that include secondary endpoint data

Not just the approved indications: FDA to study DTC drug ads that include secondary endpoint data

Source: 
Endpoints
News Tags: 
snippet: 

While most of the world bans direct-to-consumer advertising for prescription drugs, the FDA said Friday that it’s launching a study into how people might perceive such ads that include information on secondary endpoints that are not part of an approved indication.